Nucleome Informatics Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 16-11-2024
- Paid Up Capital ₹ 0.10 M
as on 16-11-2024
- Company Age 12 Year, 26 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 17.00 Cr
as on 16-11-2024
- Revenue 26.52%
(FY 2023)
- Profit 2.01%
(FY 2023)
- Ebitda -57.86%
(FY 2023)
- Net Worth 5.14%
(FY 2023)
- Total Assets 2.41%
(FY 2023)
About Nucleome Informatics
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹17.00 Cr.
Dushyant Singh and Vidhya Kesavadas serve as directors at the Company.
- CIN/LLPIN
U24230GJ2012PTC072774
- Company No.
072774
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Nov 2012
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Nucleome Informatics Private Limited offer?
Nucleome Informatics Private Limited offers a wide range of products and services, including Research and Development (R&D) Work, Product Development Research, Bioinformatics Services, Medical Test Services, Sequencing Analysis Services, Accounting & Billing Software, Billing Software.
Who are the key members and board of directors at Nucleome Informatics?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Dushyant Singh  | Director | 23-Nov-2012 | Current |
| Vidhya Kesavadas | Director | 26-Feb-2021 | Current |
Financial Performance and Corporate Structure Insights of Nucleome Informatics.
Nucleome Informatics Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 26.52% increase. The company also saw a slight improvement in profitability, with a 2.01% increase in profit. The company's net worth moved up by a moderate rise of 5.14%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nucleome Informatics?
In 2023, Nucleome Informatics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 21 Nov 2021 | ₹10.00 Cr | Open |
Others Creation Date: 27 Sep 2018 | ₹7.00 Cr | Open |
How Many Employees Work at Nucleome Informatics?
Nucleome Informatics has a workforce of 19 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nucleome Informatics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nucleome Informatics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
